Aleksandr Piroyan

3.8k total citations · 2 hit papers
11 papers, 3.2k citations indexed

About

Aleksandr Piroyan is a scholar working on Molecular Biology, Biomaterials and Organic Chemistry. According to data from OpenAlex, Aleksandr Piroyan has authored 11 papers receiving a total of 3.2k indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 5 papers in Biomaterials and 2 papers in Organic Chemistry. Recurrent topics in Aleksandr Piroyan's work include RNA Interference and Gene Delivery (6 papers), Nanoparticle-Based Drug Delivery (5 papers) and Advanced biosensing and bioanalysis techniques (3 papers). Aleksandr Piroyan is often cited by papers focused on RNA Interference and Gene Delivery (6 papers), Nanoparticle-Based Drug Delivery (5 papers) and Advanced biosensing and bioanalysis techniques (3 papers). Aleksandr Piroyan collaborates with scholars based in United States, Russia and United Kingdom. Aleksandr Piroyan's co-authors include Alexander V. Kabanov, Natalia L. Klyachko, Elena V. Batrakova, Matthew J. Haney, Yuling Zhao, Marina Sokolsky‐Papkov, Evgeniya G. Plotnikova, Tejash Patel, Richa Gupta and Zhijian He and has published in prestigious journals such as Biomaterials, Journal of Controlled Release and Pharmaceutical Research.

In The Last Decade

Aleksandr Piroyan

11 papers receiving 3.1k citations

Hit Papers

Exosomes as drug delivery vehicles for Parkinson's diseas... 2015 2026 2018 2022 2015 2015 500 1000 1.5k

Peers

Aleksandr Piroyan
Matthew J. Haney United States
Raman Bahal United States
Hongwei Chen United States
Mei Lin China
Soonhag Kim South Korea
Aleksandr Piroyan
Citations per year, relative to Aleksandr Piroyan Aleksandr Piroyan (= 1×) peers Zhijian He

Countries citing papers authored by Aleksandr Piroyan

Since Specialization
Citations

This map shows the geographic impact of Aleksandr Piroyan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Aleksandr Piroyan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Aleksandr Piroyan more than expected).

Fields of papers citing papers by Aleksandr Piroyan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Aleksandr Piroyan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Aleksandr Piroyan. The network helps show where Aleksandr Piroyan may publish in the future.

Co-authorship network of co-authors of Aleksandr Piroyan

This figure shows the co-authorship network connecting the top 25 collaborators of Aleksandr Piroyan. A scholar is included among the top collaborators of Aleksandr Piroyan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Aleksandr Piroyan. Aleksandr Piroyan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
Hingtgen, Shawn, Myoung Soo Kim, Aleksandr Piroyan, et al.. (2020). Development of exosome-encapsulated paclitaxel to overcome MDR in cancer cells. UNC Libraries. 1 indexed citations
2.
Patel, Niravkumar R., Aleksandr Piroyan, Srinivas Ganta, et al.. (2018). In Vitro and In Vivo evaluation of a novel folate-targeted theranostic nanoemulsion of docetaxel for imaging and improved anticancer activity against ovarian cancers. Cancer Biology & Therapy. 19(7). 554–564. 34 indexed citations
3.
Patel, Niravkumar R., Aleksandr Piroyan, Amanda W. Keeler, et al.. (2016). Design, Synthesis, and Characterization of Folate-Targeted Platinum-Loaded Theranostic Nanoemulsions for Therapy and Imaging of Ovarian Cancer. Molecular Pharmaceutics. 13(6). 1996–2009. 34 indexed citations
4.
Kim, Myoung Soo, Matthew J. Haney, Yuling Zhao, et al.. (2015). Development of exosome-encapsulated paclitaxel to overcome MDR in cancer cells. Nanomedicine Nanotechnology Biology and Medicine. 12(3). 655–664. 1215 indexed citations breakdown →
5.
Ganta, Srinivas, Amit Singh, Praveen Kulkarni, et al.. (2015). EGFR Targeted Theranostic Nanoemulsion for Image-Guided Ovarian Cancer Therapy. Pharmaceutical Research. 32(8). 2753–63. 26 indexed citations
6.
Haney, Matthew J., Natalia L. Klyachko, Yuling Zhao, et al.. (2015). Exosomes as drug delivery vehicles for Parkinson's disease therapy. Journal of Controlled Release. 207. 18–30. 1590 indexed citations breakdown →
7.
Biswas, Swati, Namita S. Dodwadkar, Aleksandr Piroyan, & Vladimir P. Torchilin. (2012). Surface conjugation of triphenylphosphonium to target poly(amidoamine) dendrimers to mitochondria. Biomaterials. 33(18). 4773–4782. 140 indexed citations
8.
Piroyan, Aleksandr, et al.. (2012). Convenient synthetic route to 3-cyanopyridine-2(1 H )-one derivatives with aromatic substituents. Heterocyclic Communications. 18(5-6). 233–237. 2 indexed citations
9.
Koshkaryev, Alexander, Aleksandr Piroyan, & Vladimir P. Torchilin. (2012). Increased apoptosis in cancer cells in vitro and in vivo by ceramides in transferrin-modified liposomes. Cancer Biology & Therapy. 13(1). 50–60. 70 indexed citations
10.
Koshkaryev, Alexander, Aleksandr Piroyan, & Vladimir P. Torchilin. (2012). Bleomycin in octaarginine-modified fusogenic liposomes results in improved tumor growth inhibition. Cancer Letters. 334(2). 293–301. 43 indexed citations
11.
Ananikov, Valentine P., et al.. (2009). Sulfur-containing alkenes—A new class of chelating ligands: Synthesis, coordination to palladium, and structure of the resulting complexes. Russian Journal of Organic Chemistry. 45(12). 1743–1754. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026